Emsyn Met Tablets 12.5/500 mg

Emsyn Met Tablets contain a combination of empagliflozin and metformin, used for the management of type 2 diabetes mellitus in adults who require improved blood sugar control, This dual therapy provides a complementary approach to managing glucose levels through two different mechanisms, Empagliflozin, an SGLT2 inhibitor, works by reducing the reabsorption of glucose in the kidneys, allowing excess sugar to be excreted through urine, This helps lower blood glucose levels independently of insulin, Metformin, a biguanide, works by decreasing glucose production in the liver, reducing intestinal glucose absorption, and improving insulin sensitivity in peripheral tissues, Together, these actions help control both fasting and post-meal blood sugar levels, reduce HbA1c, and improve overall metabolic balance, This combination is particularly beneficial in patients with insulin resistance, high HbA1c, or inadequate control with single therapy, Additionally, empagliflozin has been associated with cardiovascular and renal protective benefits in appropriate patients, With regular use under doctor supervision, Emsyn Met helps reduce the risk of long-term diabetes complications affecting the heart, kidneys, nerves, and eyes, while supporting better daily glucose management.

Price: Rs. 257.01

• Manufacturer
  Searle Pakistan (Pvt) Ltd.
• Generic name
  Empagliflozin , Metformin HCl
• Pack size
  1 Box = 2 Strip | 1 Strip = 7 Tablets
• Availability
  In stock
• Prescription required
  Yes